STERIS plc (NYSE:STE) to Issue Quarterly Dividend of $0.69

STERIS plc (NYSE:STE) declared a quarterly dividend on Wednesday, October 28th. Shareholders of record on Tuesday, November 17th will be paid a dividend of $0.69 per share by the medical equipment provider on Thursday, December 17th. This represents a $2.76 dividend on an annualized basis and a yield of 1.2%. The ex-dividend date of this dividend is Tuesday, November 17th.

STERIS has increased its dividend payment by an average of 0.1% per year over the last three years and has raised its dividend annually for the last 20 consecutive years. STERIS has a dividend payout ratio of 25.1% indicating that its dividend is sufficiently covered by earnings. Analysts expect STERIS to earn $12.40 per share next year, which means the company should continue to be able to cover its $2.76 annual dividend with an expected future payout ratio of 22.3%.

STERIS Stock Down 0.0%

NYSE STE opened at $228.46 on Thursday. The company has a current ratio of 1.91, a quick ratio of 1.35 and a debt-to-equity ratio of 0.23. The stock’s 50 day moving average is $220.07 and its two-hundred day moving average is $225.49. The company has a market capitalization of $22.27 billion, a price-to-earnings ratio of 27.93 and a beta of 0.92. STERIS has a 1-year low of $195.14 and a 1-year high of $269.44.

STERIS (NYSE:STE) last released its quarterly earnings data on Wednesday, August 5th. The medical equipment provider reported $2.59 earnings per share for the quarter, beating the consensus estimate of $2.49 by $0.10. The company had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.49 billion. STERIS had a return on equity of 14.34% and a net margin of 13.34%. The company’s revenue was up 7.3% compared to the same quarter last year. During the same period in the prior year, the company posted $2.34 EPS. STERIS has set its FY 2027 guidance at 11.000-11.300 EPS. Equities analysts forecast that STERIS will post 11.17 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the stock. UBS Group dropped their target price on shares of STERIS from $275.00 to $270.00 and set a “buy” rating for the company in a research report on Friday, August 7th. Piper Sandler restated an “overweight” rating and issued a $275.00 price target (up from $270.00) on shares of STERIS in a research report on Friday, August 7th. Wall Street Zen cut shares of STERIS from a “strong-buy” rating to a “buy” rating in a research note on Sunday, October 11th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of STERIS in a report on Monday, August 24th. Three investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, STERIS has an average rating of “Moderate Buy” and a consensus price target of $271.33.

STERIS Company Profile

STERIS plc (NYSE: STE) provides products and services designed to support infection prevention, procedural care and the safe manufacture of healthcare and life sciences products. Its offerings include surgical equipment and operating-room solutions, sterilization and decontamination systems, endoscopy products, cleaning and disinfection technologies, and related consumable products.

The company also provides outsourced sterilization and laboratory services through its Applied Sterilization Technologies business.